Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
CardieX ( (AU:CQT) ) has issued an update.
CONNEQT Health’s CONNEQT Pulse arterial health monitor has been named one of the “Best Blood Pressure Monitors of 2026” by AARP and singled out for providing the “Most Comprehensive Data” among devices evaluated. AARP’s endorsement, given its status as a highly trusted organisation for Americans over 50, underscores Pulse’s differentiated cardiovascular insights, including central blood pressure and arterial health metrics, and is expected to bolster CONNEQT’s positioning as a category leader in advanced arterial health monitoring while supporting its expanding U.S. commercial operations.
The recognition aligns with CONNEQT’s strategy to bring clinically meaningful cardiovascular analytics into the home and strengthens its appeal among populations at higher risk of hypertension and cardiovascular disease. Management believes the accolade will increase consumer awareness and validate the company’s technology-driven approach as it scales its presence in the large and growing U.S. market for remote and home-based cardiovascular monitoring solutions.
More about CardieX
CONNEQT Health Limited is a medical technology company focused on vascular health, offering medical and home health devices and digital solutions for hypertension, cardiovascular disease and related disorders. Its products are built on the company’s proprietary SphygmoCor vascular biomarker technology and are aimed at both clinical and consumer markets, with the company listed on the Australian Securities Exchange under the ticker CQT.
Average Trading Volume: 533,668
Technical Sentiment Signal: Sell
Current Market Cap: A$20.21M
See more insights into CQT stock on TipRanks’ Stock Analysis page.